摘要
冠状动脉粥样硬化是脉管系统常见的慢性疾病,以血管壁慢性炎症为特征。小鼠冠状动脉粥样硬化模型中发现Th1细胞是冠状动脉粥样硬化发病中关键的病理因素。
出处
《实用心脑肺血管病杂志》
2011年第1期149-152,共4页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
参考文献36
-
1Hansson GK, Libby P. The immune response in atheroselerosis: a double- edged sword [J]. Nat Rev Immunol, 2006, 6:508 -519.
-
2Zhou XA, Nicoletti R, Elhage, et al. Transfer of CD4^+ T cells aggravates atherosclerosis in immunodefi cicnt apolipoprotein E knockout mice [J]. Circulation, 2000, 102:2919-2922.
-
3Davenport P, Tipping PG. The role of interleukin -4 and interleukin - 12 in the progression of atherosclerosis in apolipoprotein E - deft cient mice [J]. AmJPathol, 2003, 163: 1117-1125.
-
4Whitman SC, Ravisankar P, Daugherty A. lnterleukin - 18 enhances atherosclerosis in apolipoprotein E mice through release of interferon - gamma [J]. Circ Res, 2002, 90: E34-E38.
-
5Gupta S, Pablo AM, Jiang X, et al. IFN -gamma potentiates atherosclerosis in ApoE knock - out mice [ J]. Clin Invest, 1997, 99: 2752 - 2761.
-
6Buono C, Binder C J, Stavrakis G, et al. T - bet deficiency reduces atheroselerosis and alters plaque antigen - speeifi e immune responses [J]. Proc Natl Aead Scl USA, 2005, 102:1596 -1601.
-
7De - Boer O J, Vander - Wal AC, Verhagen CE, et al. Cytokine secretion profi les of cloned T cells from human aortic atherosclerotic plaques [J]. J Pathol, 1999, 188: 174-179.
-
8Davenpolt P, Tipping PG. The role of interleukin- 4 and interleukin - 12 in the progression of atheroselerosis in apolipoprotein E - deft eient mice [J]. Am JPathol, 2003, 163:1117 -1125.
-
9Binder CJ, Hartvigsen K, Chang MK, et al. IL-5 links adaptive and natural immunily specific for epitopes of oxidized LDL and protects from atherosclerosis [ J]. J Clin Invest, 2004, 114 : 427 -437.
-
10Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin - 1 -like cytokine that signals via the IL - 1 receptorrelated protein ST2 and induces T helper type 2 - associated cytokines [ J]. Immunity, 2005, 23 : 479 -490.
同被引文献28
-
1Persson J,Nilsson J,Lindholm MW. Interleukin-lbeta and tumour necrosis factor-alpha impede neutral lipid turn over in macrophage- derived foam cells[J].BMC Immunology,2008,9:70.
-
2Stegger JG,Schmidt EB,Tjonneland A,et al. Single Nucleotide Polymorphisms in IL1B and the Risk of Acute Coronary Syndrome: A Danish Case-Cohort Study[J]. PLoS One,2012,7(6):e36829.
-
3Ait-Oufella H,Taleb S,Mlalat Z,et al. Recent advnaces on the role of eytokinse in atherosclerosi s[J]. Arterieseler Thromb Vsoc Biol,2011,31 (5):969-79.
-
4Jenny NS,Brown ER,Detrano R,et al. Associations of inflammatory markers with coronary artery calcification: results from the Multi- Ethnic Study of Atherosclerosis[J]. Atherosclerosis,2010,209 (1):226-9.
-
5Tretjakovs P,Jurka A,Bormane I,et al. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients[J]. Eur J Internal Med,2009,20(7):712-7.
-
6Ridker PM,Rifai N,Stampfer MJ,et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthymen[J]. Circulation,2000,101 ( 15): 1767 -72.
-
7Ueda K,Takahashi M,Ozawa K,et al. Decresaed soluble interleukin-6 receptor in patient swith acute mycoardial infarction[J]. Am Heart J,1999,138(5):908-15.
-
8Koenig W,Khuseyinova N.Biomarkers of atherosclerotic plaque instability and rupture Arterioscle[J]. Thromb Vase Biol,2007,27( 1 ): 15-26.
-
9Zamani P,Schwavtz GG,Olsson AG,et a/. Inflammatory Biomarkers,Death,and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study[J].J Am Heart Assoe,2012,2(1):e003103.
-
10Rajendran K,Devarajan N,Ganesan M,et al. Obesity, Inflammation and Acute Myocardial Infarction Expression of leptin,IL-6 and high Sensitivy-CRP in Chennai based population[J]. Thromb J,2012,10(1):13.
二级引证文献17
-
1丁宏辉,黄河澄,彭伟鹏,马杰生,刘骏达.原发性肺癌并发静脉血栓栓塞症临床特征及结局研究[J].中国基层医药,2015,22(2):220-223. 被引量:4
-
2赵俊文.冠脉介入对冠心病患者血流及炎症因子的影响[J].实用临床医药杂志,2015,19(5):1-4. 被引量:7
-
3冯睿婷.探究急性冠脉综合征患者外周免疫细胞的变化及临床意义[J].临床医药文献电子杂志,2015,2(15):2926-2926.
-
4朱光辉,李常青,李欣.规律性有氧运动对成年人血浆白介素-6水平影响的Meta分析[J].体育科学,2015,35(10):90-96. 被引量:13
-
5李敏.肺栓塞症与炎症因子的研究进展[J].当代医学,2016,22(2):11-12. 被引量:2
-
6周兴宏,刘晓瑜,温子云,何泽淮,程赛博,张宇,赵丹丹,苏志杰,周凤华,贾钰华.三七皂苷R1上调miR-146a水平和减轻ApoE^(-/-)小鼠肝脏炎症损伤的研究[J].中药新药与临床药理,2016,27(3):317-321. 被引量:11
-
7许晓伟,刘亚丽,苏维芳.瑞舒伐他汀治疗对急性冠脉综合征患者颈动脉斑块以及炎性因子的影响[J].国际老年医学杂志,2016,37(5):205-208. 被引量:7
-
8陶敏,郑康超,肖淼淼,肖辉雪,杨向俐,施维,田磊,吕家高.IL-6与冠心病相关性的研究进展[J].华中科技大学学报(医学版),2016,45(5):585-587. 被引量:17
-
9孙宇飞,郭大璘.炎症因子与冠心病关系的研究进展[J].中国当代医药,2017,24(1):12-15. 被引量:31
-
10彭博,赵贵芳,齐玲.核因子κB信号转导通路介导冠心病发生发展的机制[J].吉林医药学院学报,2018,39(3):206-209.
-
1李艳敏,成旭明.糖皮质激素治疗支气管哮喘急性发作期患者血清IL-18、IL-33水平的变化及临床意义[J].实用药物与临床,2013,16(10):897-899. 被引量:10
-
2付娟,徐昉.白介素-33在急性呼吸窘迫综合征中的研究进展[J].重庆医科大学学报,2016,41(4):425-428. 被引量:6
-
3李小燕,李亚琴,丁博,周渊,李晓丽.喜炎平注射液联合阿奇霉素序贯疗法对肺炎支气管肺炎患者血清IL-33、IL-6及TNF-α水平的影响[J].现代生物医学进展,2017,17(4):654-656. 被引量:25
-
4李天亮,陈宇,王文杰,王玉明,金素苓.来氟米特与柳氮磺吡啶分别联合甲氨蝶呤治疗强直性脊柱炎对患者血清IL-33、瘦素水平的影响[J].临床合理用药杂志,2015,8(22):88-89. 被引量:4
-
5罗天雯,刘华,王小军,董蕙,刘小平.支气管哮喘患者血浆中IL-33及可溶性ST2的水平和临床意义[J].国际呼吸杂志,2015,35(11):801-804. 被引量:1
-
6黄文辉,陈瑞林,曾颖瑜,林泽英.类风湿性关节炎患者血清白介素-33、肿瘤坏死因子-α、C反应蛋白的水平变化及意义[J].实用临床医药杂志,2013,17(15):5-7. 被引量:4
-
7黄巍,陈哲,王代平.IL-33在类风湿关节炎合并间质性肺炎患者中的表达及意义[J].临床肺科杂志,2014,19(7):1213-1216. 被引量:2
-
8陈春叶,范莹,季刚,陶玲卉.脓毒症患者血浆白介素-33的变化规律及其临床价值[J].中国医学前沿杂志(电子版),2016,8(11):117-120. 被引量:3
-
9王泽兰,沈天然,李真,凌文华.血清白介素-33对非酒精性脂肪性肝病的诊断价值分析[J].华南预防医学,2014,40(2):101-104. 被引量:2
-
10赖道权,邓勇,邱艳,邱自辉,欧书强,陈宇,邓峥.白介素-33和白介素-35在乙型肝炎治疗前后的变化及意义[J].肝脏,2016,21(10):838-840. 被引量:9